0 Items - $0.00
Categories
A to Z

Alternative structural projections:

Sp-8-pCPT-cGMPS

8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-cGMPS ), sodium salt
Membrane-permeant and PDE-resistant PKG agonist
Cat. No.: C 014
    
CAS No.: [160385-87-5]
Shipping: ambient
Product Name Price (net) Qty
Cat. No.: C 014-05
Unit: 5 µmol / ~2.6 mg
$188.00
Specially purified grade, fluorescent impurities removed. For other salt forms please inquire. Activator of protein kinase G type I α and type II. Caution: Protein kinase A type II is activated as well. Excellent cell membrane permeability and phosphodiesterase stability. Detailed technical information and updated reference list available on request. References: Butt et al., Eur. J. Pharmacol., 269, 265 - 268 (1994), Gamm et al., J. Biol. Chem., 270, 27380 - 27388 (1996).
Cat. No. C 014
Patent Information Protected under patents US 5,625,056 and DE 42 17679  issued to BIOLOG LSI
CAS number [160385-87-5]
Purity > 99% HPLC
Salt form Sodium
Storage temperature -20°C / -4°F
Light-sensitive True
Molecular formula C₁₆H₁₄ClN₅O₆PS₂ · Na
Molecular weight [g/mol] 525,9
Modifications 8-cGMP
Target PKG (cGK) Activator
Lipophilicity 2.66
Absorption max [nm] 276
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] 21500